Marga Nijenhuis

13PUBLICATIONS
10CO-AUTHORS
PharmacogenomicsGene and molecular therapyToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 12, 2026
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and CYP2C19 and tricyclic antidepressants.

Kristian Kleine Schaars, Marga Nijenhuis, Bianca Soree

|Nov 29, 2025
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between TPMT/NUDT15 and thiopurines.

Marieke J H Coenen, Marga Nijenhuis, Bianca Soree

|Dec 15, 2024
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between SLCO1B1 and statins and CYP2C9 and sulfonylureas.

David F G J Wolthuis, Marga Nijenhuis, Bianca Soree

|Jul 02, 2024
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants.

Lianne Beunk, Marga Nijenhuis, Bianca Soree

|Apr 03, 2024
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs.

Lisanne E N Manson, Marga Nijenhuis, Bianca Soree

|Mar 31, 2023
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.

Lianne Beunk, Marga Nijenhuis, Bianca Soree

Pageof 3